Sumitomo Chemical India Ltd (SUMICHEM) Q1 FY27 Results Analysis: PAT Grows 20%, Margin Expands 198 bps

Sumitomo Chemical India Ltd's Q1 FY27 numbers came in mixed, with revenue of Rs. 1,063.35 Cr (+0.62% YoY) and PAT growth of +20.46% YoY. Here's a quick read of what worked, what to watch, and what management said.

Quarter Snapshot

Revenue was flat YoY as delayed monsoon impacted kharif volumes, but EBITDA margin expanded 198 bps to 26.39%, beating the >20% target. PAT grew 20% YoY, partly due to an insurance claim. The raw material cost tailwind from the zero-duty window expires in Q2, posing a near-term margin risk.

Key Investment Insights

Key Positives

• EBITDA margin expanded 198 bps YoY to 26.39%, exceeding the company's >20% target.
• PAT attributable to owners grew 20.46% YoY to Rs.214.83 crore.
• Raw material cost ratio improved 112 bps YoY to 60.81% of revenue.
• Normalized PAT (excluding exceptional gain) grew ~9.23% YoY.
• Finance costs remain negligible at 0.19% of revenue, reflecting a debt-free balance sheet.

Risk Factors

• Revenue was nearly flat YoY (+0.62%) due to delayed monsoon and weak kharif sowing.
• The zero-duty import window on chemical inputs expired on 30 Jun 2026, removing the raw material cost tailwind for Q2.
• Subsidiaries contributed a net loss of Rs.1.70 crore to consolidated PAT.